Related Experiment Video
Updated: Aug 8, 2025
08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
9.1K
Parkinson's disease or multiple system atrophy: potential separation by quantitative susceptibility mapping.
Franz Marxreiter1,2, Vera Lambrecht3, Angelika Mennecke4
1Department of Molecular Neurology, University Hospital Erlangen, Schwabachanlage 6, 91054 Erlangen, Germany.
Therapeutic Advances in Neurological Disorders
|February 27, 2023
Summary
Quantitative susceptibility mapping (QSM) on high-field MRI effectively differentiates multiple system atrophy (MSA) from Parkinson's disease (PD). Ultra-high-field MRI, particularly putaminal measures, shows high accuracy for early MSA diagnosis.
Area of Science:
- Neuroimaging
- Neurodegenerative Diseases
- Quantitative Susceptibility Mapping (QSM)
Background:
- Distinguishing Parkinson's disease (PD) from multiple system atrophy (MSA) is challenging due to a lack of reliable biomarkers and limitations of standard imaging.
- Quantitative Susceptibility Mapping (QSM) visualizes and quantifies key pathological hallmarks like reduced myelin and iron accumulation in neurodegenerative conditions.
- QSM shows promise as an advanced imaging technique for the differential diagnosis of Parkinsonian syndromes.
Purpose of the Study:
- To evaluate the efficacy of QSM using high-field magnetic resonance imaging (MRI) in differentiating between PD and MSA.
- To assess the diagnostic accuracy of QSM in identifying characteristic pathological changes in MSA.
Main Methods:
- QSM analysis was performed on 23 patients (9 PD, 14 MSA) and 9 controls using 3 Tesla (3T) and 7 Tesla (7T) MRI scanners.
- Susceptibility measurements were taken in specific brain regions, including the basal ganglia (putamen, pallidum) and brainstem (substantia nigra).
- Diagnostic accuracy, sensitivity, and specificity were calculated to differentiate between PD, MSA, and controls.
Main Results:
- Increased magnetic susceptibility was observed in MSA patients compared to controls and PD patients, particularly in subcortical and brainstem regions at 3T MRI.
- Susceptibility measures in the putamen, pallidum, and substantia nigra demonstrated excellent accuracy in distinguishing between PD and MSA.
- Utilizing 7T MRI significantly improved diagnostic performance, achieving near 100% sensitivity and specificity for differentiating MSA, especially in the putamen.
Conclusions:
- Putaminal magnetic susceptibility measurements, especially with ultra-high-field MRI (7T), can reliably differentiate MSA patients from PD patients and healthy controls.
- QSM on high-field MRI offers a sensitive and accurate method for early diagnosis of MSA.
- This imaging modality holds significant potential for improving the differential diagnosis in Parkinsonian syndromes.
